EA200300567A1 - Лечение состояний тревоги - Google Patents

Лечение состояний тревоги

Info

Publication number
EA200300567A1
EA200300567A1 EA200300567A EA200300567A EA200300567A1 EA 200300567 A1 EA200300567 A1 EA 200300567A1 EA 200300567 A EA200300567 A EA 200300567A EA 200300567 A EA200300567 A EA 200300567A EA 200300567 A1 EA200300567 A1 EA 200300567A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
alarm conditions
published
search report
international search
Prior art date
Application number
EA200300567A
Other languages
English (en)
Russian (ru)
Inventor
Холли Рид Томассон
Дэвид Михелсон
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA200300567A1 publication Critical patent/EA200300567A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EA200300567A 2000-11-15 2001-11-06 Лечение состояний тревоги EA200300567A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24901000P 2000-11-15 2000-11-15
US26536201P 2001-01-31 2001-01-31
PCT/US2001/027801 WO2002040006A2 (en) 2000-11-15 2001-11-06 Treatment of anxiety disorders

Publications (1)

Publication Number Publication Date
EA200300567A1 true EA200300567A1 (ru) 2004-10-28

Family

ID=26939750

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300567A EA200300567A1 (ru) 2000-11-15 2001-11-06 Лечение состояний тревоги

Country Status (16)

Country Link
EP (1) EP1395253A2 (ko)
JP (1) JP2004529073A (ko)
KR (1) KR20030051812A (ko)
CN (1) CN1822825A (ko)
AU (1) AU2002217757A1 (ko)
BR (1) BR0115301A (ko)
CA (1) CA2426069A1 (ko)
CZ (1) CZ20031339A3 (ko)
EA (1) EA200300567A1 (ko)
HR (1) HRP20030384A2 (ko)
IL (1) IL155874A0 (ko)
MX (1) MXPA03004190A (ko)
NO (1) NO20032156D0 (ko)
PL (1) PL366119A1 (ko)
SK (1) SK5422003A3 (ko)
WO (1) WO2002040006A2 (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20032380A3 (en) * 2001-03-06 2004-03-17 Eli Lilly And Company Inhibitor of monoamine uptake
CN1674907A (zh) * 2002-08-14 2005-09-28 法玛西亚普强责任有限公司 瑞波西汀在治疗热潮红中的用途
GB0309440D0 (en) * 2003-04-25 2003-06-04 Lilly Co Eli Quinolone derivatives
WO2004103356A2 (en) * 2003-05-15 2004-12-02 Eli Lilly And Company Treatment of emotional dysregulation
KR20060121178A (ko) * 2003-12-12 2006-11-28 일라이 릴리 앤드 캄파니 일과성 전신 열감, 충동 조절 장애 및 일반적인 의학상태로 인한 인격 변화 치료용 선택적 노르에피네프린재흡수 억제제
WO2009089479A2 (en) 2008-01-09 2009-07-16 Mayo Foundation For Medical Education And Research Inhibiting neurotransmitter reuptake
US20120220665A1 (en) * 2009-11-03 2012-08-30 Mayo Foundation For Medical Education And Research Inhibiting Neurotransmitter Reuptake
WO2011056788A2 (en) * 2009-11-03 2011-05-12 Mayo Foundation For Medical Education And Research Inhibiting neurotransmitter reuptake
WO2014159251A2 (en) 2013-03-14 2014-10-02 Mayo Foundation For Medical Education And Research Inhibiting neurotransmitter reuptake
JP2022519541A (ja) * 2019-02-01 2022-03-24 ホフマン・テクノロジーズ・エルエルシー 不安関連障害を処置するための組成物および方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2931997A (en) * 1996-05-07 1997-11-26 Merck & Co., Inc. Treatment of mood disorders with a growth hormone secretagogue
IT1305322B1 (it) * 1998-04-23 2001-05-04 Pharmacia & Upjohn Spa Uso di reboxetina per il trattamento di disturbi nervosi
ES2246485T3 (es) * 1999-07-01 2006-02-16 PHARMACIA & UPJOHN COMPANY LLC (s,s)-reboxetina para tratar la incontinencia.

Also Published As

Publication number Publication date
IL155874A0 (en) 2003-12-23
CZ20031339A3 (cs) 2003-10-15
CN1822825A (zh) 2006-08-23
NO20032156L (no) 2003-05-13
WO2002040006A3 (en) 2003-12-24
AU2002217757A1 (en) 2002-05-27
JP2004529073A (ja) 2004-09-24
MXPA03004190A (es) 2003-09-22
HRP20030384A2 (en) 2003-08-31
BR0115301A (pt) 2004-12-14
CA2426069A1 (en) 2002-05-23
WO2002040006A2 (en) 2002-05-23
EP1395253A2 (en) 2004-03-10
KR20030051812A (ko) 2003-06-25
NO20032156D0 (no) 2003-05-13
PL366119A1 (en) 2005-01-24
SK5422003A3 (en) 2003-12-02

Similar Documents

Publication Publication Date Title
EA200201214A1 (ru) Замещенные тиоацетамиды
EA200000351A1 (ru) Лечение кондуктивных нарушений
EA200300906A1 (ru) Новые спиротрициклические производные и их применение в качестве ингибиторов фосфодиэстеразы-7
EA200300105A1 (ru) Нестероидные ингибиторы воспалений
DE60218493D1 (de) Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
IS2170B (is) Sýklópentanóindól, efnablöndur sem innihalda slíkefnasambönd og meðhöndlunaraðferðir
HRP20010573B1 (en) Tricyclic inhibitors of poly(adp-ribose) polymerases
EA200300528A1 (ru) 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6
NO20005237D0 (no) Heterocyklisk substituerte amider anvendt som calpain- inhibitorer
EA200300836A1 (ru) Производные фталазинон-пиперидина в качестве ингибиторов pde4
EA200201252A1 (ru) Соединения, эффективные в качестве агонистов э2 - адренорецептора и ингибиторов фосфодиэстеразы pde4
EA200300567A1 (ru) Лечение состояний тревоги
DE60231107D1 (de) Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems
RS51003B (sr) Derivat piridin-1-oksida i postupak za njegovu transformaciju u farmaceutski efikasna jedinjenja
DE60325377D1 (de) Motilidverbindungen
EA200200948A1 (ru) Лечение псориаза
DE60033809D1 (de) Inhibitoren von metalloproteinasen
DK1438034T3 (da) Anvendelse af -phenyl-3-dimethylaminiopropanforbindelser til behandling af urininkontinens
EA200200798A1 (ru) Кальцилитические соединения
DK1161239T3 (da) 3- cyclopropylmethoxy-4-difluormethoxy-N-(3,5-dichlorpyrid-4-yl)benzamid til behandling af dissemineret sklerose
DE60228134D1 (de) Substituierte hydrazone als hemmer von cyclooxygenase-2
ATE345135T1 (de) Tropan-derivate mit dopamin-wiederaufnahme-hemmer-wirkung für die behandlung von ischämischen erkrankungen
DK1455770T3 (da) Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser
DE60124791D1 (de) S-Methyl-Dihydro-Ziprasidone zur Behandlung von psychiatrischen Störungen.
DE50209798D1 (de) Substituierte 2-pyrrolidin-2-yl-1h-indol-derivative für die behandlung von migräne